Keurig Green Mountain Inc (NASDAQ:GMCR) shares are up almost 19% in pre-market trading this morning following its Q4 earnings release yesterday after market close. The company posted net sales of $1.04 billion and non-GAAP earnings of $0.85 per share, beating analyst revenue estimates of $1.025 billion and earnings of 0.70 per share. The company also raised its quarterly dividend 13% to 32.5 cents a share. The company struggled with sales figures this year on its K-cups and a price decrease for its brewers. CEO Brian Kelly stated, “I’m particularly pleased with the benefits realized from our cost reduction efforts as well as our strong cash generation, both of which exceeded expectations in the fourth quarter. While we expect marketplace conditions will remain challenging in the near term, we have a stronger product line-up and price positioning as we enter the new holiday season.” According to TipRanks’ statistics, out of the 7 analysts who have rated GMRC in the last 3 months, 1 gave a Sell rating while 6 remain on the sidelines. The average 12-month price target for the stock is $54.67, marking a 35% upside from where shares last closed.
Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP) rose almost 14% in pre-market trading this morning following its Q3 earnings release yesterday after market close. China’s largest online travel agency posted non-GAAP revenues of $501 million, up 49% from the same quarter of last year and non-GAAP earnings of $2.20 per ADS, compared to 0.36 from the same quarter of last year. CEO James Liang stated “Ctrip maintained strong momentum and delivered great results in the third quarter of 2015…Both hotel and air ticketing businesses reached 50% year-over-year growth in volume. Outbound travel continued to grow at triple digit in the core business segments due to the booming demand this quarter. Meanwhile, the Ctrip team has demonstrated its strong execution through significant improvement in operational efficiency.” Analyst Michael Olsen of Piper Jaffray reiterated a Buy rating for the stock, raising his price target from $115 to $125 following earnings. Overall, Michael Olsen has as 64% success rate recommending stocks with an average return of 9.4% per recommendation. According to TipRanks’ statistics, out of the 8 analysts who have rated CTRP in the last 3 months, all 8 gave a Buy rating. The average 12-month price target for the stock is $108.38, marking a 14% upside from where shares last closed.
Celladon Corp (NASDAQ:CLDN) soared almost 85% in pre-market trading this morning following an announcement of a merger between the company and Eiger BioPharmaceuticals. This merger will combine the two companies operations, with Eigers stock holders will become majority owners of Celladon. The merger is still pending the approval of Celladon stockholders. Investors from capital management firms will invest $39.5 million to finance this merger. Top management of Celladon will resign and the current leaders of Eiger will serve as the combined company’s management, including Eiger’s CEO David Cory.